News Conference News AHA 2021 No Benefit for Icosapent Ethyl, P2Y12 Inhibitors in Separate COVID-19 Trials Todd Neale November 15, 2021
News Conference News AHA 2021 Bentracimab Rapidly, Safely Reverses Ticagrelor in Early REVERSE-IT Data Yael L. Maxwell November 15, 2021
News Conference News AHA 2021 RAPID CABG: No Penalty to Early Surgery for ACS After Stopping Ticagrelor Yael L. Maxwell November 13, 2021
News Conference News TCT 2021 Conservative Management, Careful Diagnosis Key for Good SCAD Outcomes Yael L. Maxwell November 09, 2021
News Conference News ESC 2021 OAC Analysis From MASTER DAPT Raises No Red Flags for Shorter DAPT Shelley Wood September 02, 2021
News Conference News In ACS, Clopidogrel Monotherapy After 1-Month DAPT Falls Short: STOPDAPT-2 ACS Shelley Wood August 30, 2021
News Conference News ESC 2021 MASTER DAPT: One Month's Enough in Patients at High Bleeding Risk Shelley Wood August 28, 2021
News Conference News ESC 2021 Prasugrel Tops Ticagrelor in ACS Across the eGFR Spectrum: ISAR-REACT 5 Todd Neale August 24, 2021
News Conference News ACC 2021 Extended TAILOR-PCI Data Again Show No Gains for Genotype-Guided Meds Yael L. Maxwell May 26, 2021
News Conference News EuroPCR 2021 Subcutaneous GP IIb/IIIa Inhibitor in STEMI Is Fast, Potent in Early Study Todd Neale May 18, 2021
News Conference News ACC 2021 TALOS-AMI Supports Clopidogrel De-escalation After Earlier Ticagrelor Post-PCI Yael L. Maxwell May 17, 2021
News Conference News SCAI 2021 Chinese Registry Supports Prolonged DAPT Following PCI for ACS Yael L. Maxwell May 03, 2021